Robert Charles Swanton - 12 Aug 2025 Form 4 Insider Report for BICYCLE THERAPEUTICS PLC (BCYC)

Role
Director
Signature
/s/ Travis Thompson, Attorney-in-Fact
Issuer symbol
BCYC
Transactions as of
12 Aug 2025
Net transactions value
$0
Form type
4
Filing time
14 Aug 2025, 16:26:11 UTC
Next filing
06 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Swanton Robert Charles Director C/O BICYCLE THERAPEUTICS PLC, BLOCKS A & B, PORTWAY BUILDING, CAMBRIDGE, UNITED KINGDOM /s/ Travis Thompson, Attorney-in-Fact 14 Aug 2025 0002079922

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Award $0 +12,500 +405% $0.000000 15,589 12 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (right to buy) Award $0 +25,000 $0.000000 25,000 12 Aug 2025 Ordinary Shares 25,000 $7.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted share unit ("RSU") award. The RSUs will vest in three equal installments on each of August 12, 2026, August 12, 2027 and August 12, 2028.
F2 Each RSU represents a contingent right to receive one ordinary share.
F3 This option will vest in three equal installments on each of August 12, 2026, August 12, 2027 and August 12, 2028.